Abstract
Stroke is a complex neurological disorder, and the risk factors and genetic biomarkers associated with stroke development are not completely understood. This study aims to identify putative causal traits and their biomarkers that influence the risk of stroke. Here the latent causal variable (LCV) method has been used to investigate the potential causal genetic relationships between large-scale genome-wide association studies (GWAS) data of 1504 complex traits from UK Biobank and stroke. Generalised Mendelian randomisation (GSMR) method has also been further used to examine causal inference. These analyses suggest 14 causal traits associated with stroke risk (|GCP|> 0.60; FDR < 0.05), including atrial fibrillation, deep venous thrombosis, gamma-glutamyl transferase, and platelet crit. Gene-based analysis has revealed shared genes, providing novel insights into the genetic biomarkers of the causal traits on stroke risk. Functional enrichment analyses of the shared genes have provided biological pathways underlying biological mechanisms to stroke risk, including “oxidative damage”, “platelet activation”, “cell aging”, and others. This study provides causal evidence of cardiovascular, metabolic, and blood clot-related traits increasing stroke risk. The identified shared gene biomarkers provide valuable insights into the shared genetic biomarkers and underlying mechanisms linking causal traits to stroke risk.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study does not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We have expanded our study including several analysis such as Generalized Mendelain Randomization (GSMR), Gene-based test and functional enrichment analysis. We have edited text incorporting the above analyses.
